The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Compositions Comprising A Jak Inhibitor - EP3595667

The patent EP3595667 was granted to Alfasigma on Dec 20, 2023. The application was filed on Mar 12, 2018 under application number EP18713553A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3595667

ALFASIGMA
Application Number
EP18713553A
Filing Date
Mar 12, 2018
Status
Granted And Under Opposition
Nov 17, 2023
Publication Date
Dec 20, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
POLPHARMASep 20, 2024ELKINGTON AND FIFEADMISSIBLE
BOTTI & FERRARISep 17, 2024BOTTI & FERRARIADMISSIBLE
TEVA PHARMACEUTICALSSep 17, 2024D YOUNGADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS8563545
DESCRIPTIONWO2015117980
INTERNATIONAL-SEARCH-REPORTWO2015117980
INTERNATIONAL-SEARCH-REPORTWO2015117981
INTERNATIONAL-SEARCH-REPORTWO2017012770
OPPOSITIONUS2016376269
OPPOSITIONUS9382247
OPPOSITIONWO03032954
OPPOSITIONWO2015117980
OPPOSITIONWO2015117981
OPPOSITIONWO2017012770

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents